Two food-related names and one in health care look like promising investments right now.
Time to review the charts and indicators.
NVCR's prices are poised to head higher in the months ahead.
Let's see what the charts have to say.
Shares of the provider of animal health technology could afford to see more development and sideways price action after their big post-earnings jump.
Let's find a trainer versed in technical analysis as we check out the charts.
The maker of glucose monitoring equipment saw its shares shoot higher last week on a big earnings beat and the rise may not be over.
Despite stories of questionable use of health care data, my concern with GOOGL is technical: We need a retest of $1,250 to $1,275 before we can move significantly higher.
Let's check out the charts of this medical technologies company.
Let others wait and see if someone comes in with a better offer than Alphabet's bid for Fitbit; this value investor is taking his profit and leaving the table.